Arvinas, Inc. (NASDAQ: ARVN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $15.00 to $12.00. They now have a "neutral" rating on the stock.
Arvinas, Inc. (ARVN): Among Stocks Under $10 that Will Triple [Yahoo! Finance]
Arvinas, Inc. (NASDAQ: ARVN) had its price target lowered by analysts at Truist Financial Co. from $65.00 to $21.00. They now have a "buy" rating on the stock.
Arvinas, Inc. (NASDAQ: ARVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $81.00 price target on the stock.
Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation [Yahoo! Finance]